12th European HIV & Hepatitis Workshop 2014

Freepik_Barcelona865284_43799028_web

Dear Colleagues,

We proudly announce the 12th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, to be held in

Barcelona, Spain on 26 - 28 March 2014
at the Fira Palace Hotel

The European HIV and Hepatitis meeting was started 12 years ago with the objective to provide clinical virologists and other infectious diseases treating specialists involved in both research and clinical practice with the opportunity to share data and discuss their clinical application. The focus of the workshop at the time was specifically on HIV antiretroviral drug resistance, which was the main challenge facing the clinician a decade ago. Hence the original name as the European Drug Resistance workshop.

Over the years the challenges facing European clinicians treating HIV patients expanded. As resistance was better understood and managed, broader treatment issues (adherence, toxicity, etc.) were added to the workshop. Similarly, as better treatments for HCV became available, many of them were required to treat viral Hepatitis as well. Therefore the workshop (and its name) were expended to keep pace with the needs of the European clinicians – The European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance. Although resistance is still an important feature of the meeting, the other key topics in treatment strategies are addressed – similarly although HIV remains very much a key component – treatment of Hepatitis infection is also included. Of note, although the topic of HIV/Hepatitis co-infection is touched on if relevant to a specific issue – it is not the focus of the workshop nor a major topic during presentation and discussion.

We invite you to attend the 12th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance and encourage you to submit abstracts on your research in this field.

We hope to see you in Barcelona!

On behalf of the Organizing Committee,

Claus Nielsen, MSc, PhD - Statens Serum Institut, Copenhagen, Denmark
Jean-Claude Schmit MD, PhD - Centre Hospitalier de Luxembourg, Luxembourg

Chairs 2014